History: in 2019, Fleming Scientific adapted its computational nonlinear dynamics software for use with mobile phone capture auscultation. Mobile phones are powerful devices that support very high recording speeds and show good infrasonic sensitivity.
After initial clinical success, TSI was formed. TSI develops key research collaborations and raises non-dilutive funding to progress work in its key focus areas. TSI also developed a proprietary mHealth “app” that can be operationalized on about 7 billion phones globally. TSI’s original goal with the mHealth device was to make gold standard proxy information available to providers in situations where none exist today such as tele-health, low resource clinical environments and humanitarian efforts.
At TSI, our mission is simply to make new information available to providers or researchers, in the occasion of use, that optimizes treatment planning and improves outcomes. While most of our clinical study to-date has been centered on mHealth and remote patients, our scope is expanding to making commonly used non-invasive clinical devices smarter. Other applications include health security and military readiness.
David Wolfson serves as CEO. Mr. Wolfson combines a mechanical engineering background with an MBA to lead TSI’s operations. His expertise in project development, execution and portfolio governance as well as organizational management facilitates cross-functional integration and financial oversight. David works in close partnership with Fleming Scientific, which provides the core analytical expertise and technology development driving TSI.
We are grateful for the immense support from organizations such as the University of Louisville, Maine Health and Lehigh Valley Health Network.
Collaboration: we are always interested in hearing from anyone that is interested in collaborating with us or simply learning more. We welcome interested physicians, researchers, device makers, providers and payers to contact us by simply clicking here.